{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:13:15Z","timestamp":1777965195439,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>BTF3, also known as BETA-NAC, BTF3b, BTF3a, and\nNACB, is a transcription factor originally isolated from HeLa cell extracts. It forms stable\ncomplexes with RNA polymerase II and plays a critical role in transcription initiation.\nAlthough aberrant BTF3 expression has been reported in certain malignancies, its\noverall role across diverse tumor types remains poorly defined. This study aimed to elucidate\nthe functional implications of BTF3 across various cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>BTF3 expression was analyzed using datasets from The Cancer Genome Atlas\n(TCGA), including TCGA_GTEx, TCGA unpaired, and TCGA paired samples. The\nprognostic significance of BTF3 across 33 tumor types was evaluated using Kaplan-Meier\nsurvival and univariate Cox regression analyses. In cancers where BTF3 expression\nshowed prognostic value, additional clinical correlation analyses were performed. Clear\ncell renal carcinoma (sample size &gt;500) was selected for nomogram construction to illustrate\nBTF3\u2019s prognostic relevance. The association between BTF3 expression and immune\ncell infiltration was also examined, alongside functional enrichment analysis to explore\ninvolved signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>BTF3 displayed variable expression across tumor types and was significantly\ncorrelated with several clinical parameters. Survival and regression analyses identified\nBTF3 as a prognostic marker in specific cancers. The nomogram model for clear cell renal\ncarcinoma further supported its predictive value. BTF3 expression was also associated\nwith features of the tumor immune microenvironment. Functional enrichment analysis\nimplicated signaling pathways, including the tuberous sclerosis complex\/mechanistic\ntarget of rapamycin (TSC\/mTOR), phosphoinositide 3-kinase\/AKT (PI3K\/AKT), and\nrat sarcoma\/mitogen-activated protein kinase (RAS\/MAPK) in BTF3-associated tumorigenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>These findings underscore the heterogeneous expression of BTF3 across\nmalignancies and highlight its potential involvement in modulating the tumor immune\nlandscape and oncogenic signaling pathways. The results expand our understanding of\nBTF3\u2019s role in cancer biology and suggest mechanistic links to well-characterized tumorigenic\nprocesses. However, further experimental validation is necessary to substantiate\nthese associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>result:<\/jats:title>\n                    <jats:p>BTF3 displayed varied expression profiles across different tumors, associated with multiple clinical parameters and the tumor immune microenvironment. It was linked to pathways such as TSC\/mTOR, PI3K\/AKT, and RAS\/MAPK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>BTF3 may serve as a promising prognostic biomarker and a potential target\nfor immunotherapeutic intervention across multiple cancer types.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673383163251013124752","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:58:09Z","timestamp":1777964289000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic and Immunoinfiltration Analysis of Transcription Factor BTF3 in Pan-cancer"],"prefix":"10.2174","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7356-723X","authenticated-orcid":true,"given":"Xiaoxiao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Dermatology in The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology in The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Dermatology in The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Dermatology in The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673383163251013124752","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/253103\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673383163251013124752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:58:13Z","timestamp":1777964293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/253103\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673383163251013124752","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-02-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}